Methamphetamine (METH) increases the oxidative DNA lesion 8-oxoguanine (8-oxoG) in fetal mouse brain, and causes postnatal motor coordination deficits after in utero exposure. Like oxoguanine glycosylase 1 (OGG1), the Cockayne syndrome B (CSB) protein is involved in the repair of oxidatively damaged DNA, although its function is unclear. Here we used CSB-deficient Csbm/m knockout mice to investigate the developmental role of DNA oxidation and CSB in METH-initiated neurodevelopmental deficits. METH (40 mg/kg intraperitoneally) administration to pregnant Csb females on gestational day 17 increased 8-oxoG levels in Csbm/m fetal brains (p < 0.05). CSB modulated 8-oxoG levels independent of OGG1 activity, as 8-oxoG incision activity in fetal nuclear extracts was identical in Csbm/m and Csb+/+mice. This CSB effect was evident despite 7.1-fold higher OGG1 activity in Csb+/+ mice compared to outbred CD-1 mice. Female Csbm/m offspring exposed in utero to METH exhibited motor coordination deficits postnatally (p < 0.05). In utero METH exposure did not cause dopaminergic nerve terminal degeneration, in contrast to adult exposures. This is the first evidence that CSB protects the fetus from xenobiotic-enhanced DNA oxidation and postnatal functional deficits, suggesting that oxidatively damaged DNA is developmentally pathogenic, and that fetal CSB activity may modulate the risk of reactive oxygen species-mediated adverse developmental outcomes. Antioxid. Redox Signal. 14, 747–756.
Get full access to this article
View all access options for this article.
References
1.
AgrawalHC, GlissonSN, HimwichWA. Developmental changes in monoamines of mouse brain. Int J Neuropharmacol, 7:97–101. 1968.
2.
AlhavaE. Amphetamine toxicity in adult and developing mice. Acta Pharmacol Toxicol (Copenh), 31:387–400. 1972.
3.
BowyerJF. Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamine. Brain Res, 885:166–171. 2000.
4.
BowyerJF, DaviesDL, SchmuedL, BroeningHW, NewportGD, SlikkerWJr., HolsonRR. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther, 268:1571–1580. 1994.
5.
BrooksPJ. DNA repair in neural cells: basic science and clinical implications. Mutat Res, 509:93–108. 2002.
6.
CadetJL, BrannockC. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int, 32:117–131. 1998.
7.
CadetJL, JayanthiS, DengX. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J, 17:1775–1788. 2003.
8.
CadetJL, McCoyMT, LadenheimB. Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from cDNA array analyses. Synapse, 44:211–226. 2002.
9.
CapponGD, MorfordLL, VorheesCV. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res, 103:155–162. 1997.
10.
ChangL, SmithLM, LoPrestiC, YonekuraML, KuoJ, WalotI, ErnstT. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res, 132:95–106. 2004.
11.
Charlet-BerguerandN, FeuerhahnS, KongSE, ZisermanH, ConawayJW, ConawayR, EglyJM. RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors. EMBO J, 25:5481–5491. 2006.
12.
CitterioE, Van Den BoomV, SchnitzlerG, KanaarR, BonteE, KingstonRE, HoeijmakersJH, VermeulenW. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor. Mol Cell Biol, 20:7643–7653. 2000.
13.
de WaardH, de WitJ, AndressooJO, van OostromCT, RiisB, WeimannA, PoulsenHE, van SteegH, HoeijmakersJH, van der HorstGT. Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol, 24:7941–7948. 2004.
14.
de WaardH, de WitJ, GorgelsTG, van den AardwegG, AndressooJO, VermeijM, van SteegH, HoeijmakersJH, van der HorstGT. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst), 2:13–25. 2003.
15.
DianovG, BischoffC, SunesenM, BohrVA. Repair of 8-oxoguanine in DNA is deficient in Cockayne syndrome group B cells. Nucleic Acids Res, 27:1365–1368. 1999.
16.
EnglanderEW, MaH. Differential modulation of base excision repair activities during brain ontogeny: implications for repair of transcribed DNA. Mech Ageing Dev, 127:64–69. 2006.
17.
Hailer-MorrisonMK, KotlerJM, MartinBD, SugdenKD. Oxidized guanine lesions as modulators of gene transcription. Altered p50 binding affinity and repair shielding by 7,8-dihydro-8-oxo-2′-deoxyguanosine lesions in the NF-kappaB promoter element. Biochemistry, 42:9761–9770. 2003.
18.
HayashiM, ItohM, ArakiS, KumadaS, ShiodaK, TamagawaK, MizutaniT, MorimatsuY, MinagawaM, OdaM. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol, 60:350–356. 2001.
19.
HuJ, de Souza-PintoNC, HaraguchiK, HogueBA, JarugaP, GreenbergMM, DizdarogluM, BohrVA. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J Biol Chem, 280:40544–40551. 2005.
JengW, RamkissoonA, ParmanT, WellsPG. Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration. FASEB J, 20:638–650. 2006.
22.
JengW, WongAW, TingAKR, WellsPG. Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med, 39:317–326. 2005.
23.
KirkaliG, de Souza-PintoNC, JarugaP, BohrVA, DizdarogluM. Accumulation of (5′S)-8,5′-cyclo-2′-deoxyadenosine in organs of Cockayne syndrome complementation group B gene knockout mice. DNA Repair (Amst), 8:274–278. 2009.
24.
KlunglandA, RosewellI, HollenbachS, LarsenE, DalyG, EpeB, SeebergE, LindahlT, BarnesDE. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci U S A, 96:13300–13305. 1999.
25.
KohjiT, HayashiM, ShiodaK, MinagawaM, MorimatsuY, TamagawaK, OdaM. Cerebellar neurodegeneration in human hereditary DNA repair disorders. Neurosci Lett, 243:133–136. 1998.
26.
KyngKJ, MayA, BroshRMJr., ChengWH, ChenC, BeckerKG, BohrVA. The transcriptional response after oxidative stress is defective in Cockayne syndrome group B cells. Oncogene, 22:1135–1149. 2003.
27.
LeeKA, BindereifA, GreenMR. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Analysis Tech, 5:22–31. 1988.
28.
LichtCL, StevnsnerT, BohrVA. Cockayne syndrome group B cellular and biochemical functions. Am J Hum Genet, 73:1217–1239. 2003.
29.
LiuL, WellsPG. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2′-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues. Free Radic Biol Med, 19:639–648. 1995.
30.
MaddukuriL, SpeinaE, ChristiansenM, DudzinskaD, ZaimJ, ObtulowiczT, KabaczykS, KomisarskiM, BukowyZ, SzczegielniakJ, WojcikA, KusmierekJT, StevnsnerT, BohrVA, TudekB. Cockayne syndrome group B protein is engaged in processing of DNA adducts of lipid peroxidation product trans-4-hydroxy-2-nonenal. Mutat Res, 666:23–31. 2009.
31.
MartinSM, MalkinsonTJ, VealeWL, PittmanQJ. Fever in pregnant, parturient, and lactating rats. Am J Physiol, 268:R919–R923. 1995.
32.
NanceMA, BerrySA. Cockayne syndrome: review of 140 cases. Am J Med Genet, 42:68–84. 1992.
33.
NewmanJC, BaileyAD, WeinerAM. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc Natl Acad Sci U S A, 103:9613–9618. 2006.
34.
OsterodM, LarsenE, Le PageF, HengstlerJG, Van Der HorstGT, BoiteuxS, KlunglandA, EpeB. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene, 21:8232–8239. 2002.
35.
Pastoriza-GallegoM, ArmierJ, SarasinA. Transcription through 8-oxoguanine in DNA repair-proficient and Csb(-)/Ogg1(-) DNA repair-deficient mouse embryonic fibroblasts is dependent upon promoter strength and sequence context. Mutagenesis, 22:343–351. 2007.
36.
Paz-ElizurT, ElingerD, Leitner-DaganY, BlumensteinS, KrupskyM, BerrebiA, SchechtmanE, LivnehZ. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair (Amst), 6:45–60. 2007.
37.
PerilloB, OmbraMN, BertoniA, CuozzoC, SacchettiS, SassoA, ChiariottiL, MalorniA, AbbondanzaC, AvvedimentoEV. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science, 319:202–206. 2008.
38.
PlessingerMA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am, 25:119–138. 1998.
39.
PuC, VorheesCV. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res, 72:325–328. 1993.
40.
ShibutaniS, GrollmanAP. Miscoding during DNA synthesis on damaged DNA templates catalysed by mammalian cell extracts. Cancer Lett, 83:315–322. 1994.
41.
SpencerSJ, MouihateA, GalicMA, PittmanQJ. Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J Physiol, 586:399–406. 2008.
42.
SpivakG, HanawaltPC. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst), 5:13–22. 2006.
43.
ThorslundT, von KobbeC, HarriganJA, IndigFE, ChristiansenM, StevnsnerT, BohrVA. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol Cell Biol, 25:7625–7636. 2005.
44.
TuoJ, ChenC, ZengX, ChristiansenM, BohrVA. Functional crosstalk between hOgg1 and the helicase domain of Cockayne syndrome group B protein. DNA Repair (Amst), 1:913–927. 2002.
45.
TuoJ, JarugaP, RodriguezH, BohrVA, DizdarogluM. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J, 17:668–674. 2003.
46.
TuoJ, MuftuogluM, ChenC, JarugaP, SelzerRR, BroshRMJr., RodriguezH, DizdarogluM, BohrVA. The Cockayne syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA. J Biol Chem, 276:45772–45779. 2001.
47.
van der HorstGT, van SteegH, BergRJ, van GoolAJ, de WitJ, WeedaG, MorreauH, BeemsRB, van KreijlCF, de GruijlFR, BootsmaD, HoeijmakersJH. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell, 89:425–435. 1997.
48.
VenemaJ, MullendersLH, NatarajanAT, van ZeelandAA, MayneLV. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci U S A, 87:4707–4711. 1990.
49.
ViswanathanA, DoetschPW. Effects of nonbulky DNA base damages on Escherichia coli RNA polymerase-mediated elongation and promoter clearance. J Biol Chem, 273:21276–21281. 1998.
50.
WellsPG, KimPM, LaposaRR, NicolCJ, ParmanT, WinnLM. Oxidative damage in chemical teratogenesis. Mutat Res, 396:65–78. 1997.
51.
WinnLM, WellsPG. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Radic Biol Med, 22:607–621. 1997.
52.
WongAW, McCallumGP, JengW, WellsPG. Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits. J Neurosci, 28:9047–9054. 2008.
53.
ZharkovDO, RosenquistTA, GerchmanSE, GrollmanAP. Substrate specificity and reaction mechanism of murine 8-oxoguanine-DNA glycosylase. J Biol Chem, 275:28607–28617. 2000.
